Clinical Trial Update: Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of Azyter Eye Drops (T1225) for blepharitis has been completed, with results posted in November 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharitis

Drugs mentioned

• Azyter Eye Drops (azithromycin ophthalmic solution)

Snippet

Sponsor: Laboratoires Thea | Conditions: Blepharitis | Phase 2 | Status: COMPLETED | Results posted: 2014-11-04